Abstract
Isoflurane is a volatile anesthetic which decreases vascular tone. Experiments were designed to determine whether isoflurane attenuated agonist-induced signaling in cultured vascular smooth muscle cells (A7r5). Cells were preincubated for 15 to 20 min with clinically relevant concentrations of isoflurane--0.5 to 2% in the gas phase and stimulated with 10(-9) or 10(-7) M vasopressin or with 3.3 x 10(-9) M platelet-derived growth factor. The two agonists are believed to act via differing signaling pathways. Total inositol phosphate formation was measured by column chromatography. Apparent intracellular free Ca++ concentration (1) [Ca++]i was estimated using indo-1 and flow cytometry. Isoflurane attenuated increases in [Ca++]i evoked by both agonists. Isoflurane 2.0% inhibited [Ca++]i responses evoked by vasopressin by 35 to 41%. Responses due to Ca++ release from intracellular stores were particularly sensitive to inhibition by isoflurane. The anesthetic attenuated inositol phosphate generation evoked by vasopressin and platelet-derived growth factor, suggesting a mechanism for isoflurane action on Ca++ release. Surprisingly, the anesthetic only modestly inhibited increases in [Ca++]i due to Ca++ entry. Isoflurane's effect on Ca++ influx after emptying of Ca++ stores was probed using thapsigargin. Inhibition of Ca++ influx was modest. It is suggested that isoflurane attenuates total inositol phosphate formation and Ca++ release evoked by vasopressin and platelet-derived growth factor while having limited effects on agonist-induced Ca++ entry.
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|